Compare RGEN & STWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | STWD |
|---|---|---|
| Founded | 1981 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 6.4B |
| IPO Year | 1995 | 2009 |
| Metric | RGEN | STWD |
|---|---|---|
| Price | $112.94 | $18.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $167.67 | $20.00 |
| AVG Volume (30 Days) | 857.4K | ★ 2.4M |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 10.45% |
| EPS Growth | ★ 286.96 | 4.55 |
| EPS | 0.86 | ★ 1.15 |
| Revenue | $141,236,000.00 | ★ $1,844,289,000.00 |
| Revenue This Year | $14.30 | $283.44 |
| Revenue Next Year | $14.52 | $17.66 |
| P/E Ratio | $136.78 | ★ $15.94 |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $109.50 | $16.90 |
| 52 Week High | $175.77 | $20.99 |
| Indicator | RGEN | STWD |
|---|---|---|
| Relative Strength Index (RSI) | 38.96 | 56.77 |
| Support Level | $111.29 | $17.86 |
| Resistance Level | $130.12 | $18.18 |
| Average True Range (ATR) | 6.03 | 0.24 |
| MACD | -1.13 | 0.04 |
| Stochastic Oscillator | 9.65 | 67.69 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Starwood Property Trust Inc is a real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans, commercial mortgage-backed securities, and other real estate investments in the U.S., Australia, and Europe. The company has four reportable business segments: Commercial and Residential Lending, Infrastructure Lending, Property, and Investing and Servicing. The majority of its revenue is generated from the Commercial and Residential Lending segment, which engages mainly in originating, acquiring, financing, and managing commercial first mortgages, non-agency residential mortgages (residential loans), commercial mortgage-backed securities (CMBS), residential mortgage-backed securities (RMBS), and other real estate and related debt investments.